Hillary focuses her practice on advising a wide range of health care and life sciences companies on complex health care regulatory matters. She regularly advises clients on legal issues related to compliance with health care fraud and abuse laws, with an emphasis on the Anti-Kickback Statute, Stark Law, and the False Claims Act. Hillary also counsels clients on all aspects of overpayment issues and making voluntary self-disclosures, including the drafting and submission of self-disclosures to the OIG Self-Disclosure Protocol and the CMS Self-Referral Disclosure Protocol. Hillary frequently partners with clients to assess, develop, and implement compliance programs designed to ensure compliance with HHS-OIG and DOJ compliance program requirements. She also routinely advises clients on compliance matters related to developing and utilizing emerging technologies, including the implementation of telehealth programs and the integration of AI technologies into clients’ systems and workflows. Hillary’s clients include pharmaceutical and device manufacturers, charitable patient assistance organizations, hospitals and health care systems, physician group practices, and companies involved in emerging health care technologies, including telehealth companies. She also regularly coordinates with the firm’s Government Relations group on federal advocacy efforts before Congress and the US Department of Health and Human Services on behalf of health care and life sciences clients.